Literature DB >> 34856560

Management of Placental Transfusion to Neonates After Delivery.

Ryan M McAdams1, Satyan Lakshminrusimha.   

Abstract

This review summarizes high-quality evidence supporting delayed umbilical cord clamping to promote placental transfusion to preterm and term neonates. In preterm neonates, delayed cord clamping may decrease mortality and the need for blood transfusions. Although robust data are lacking to guide cord management strategies in many clinical scenarios, emerging literature is reviewed on numerous topics including delivery mode, twin gestations, maternal comorbidities (eg, gestational diabetes, red blood cell alloimmunization, human immunodeficiency virus [HIV] infection, and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection) and neonatal complications (eg, fetal growth restriction, congenital heart disease, and the depressed neonate). Umbilical cord milking is an alternate method of rapid placental transfusion, but has been associated with severe intraventricular hemorrhage in extremely preterm neonates. Data on long-term outcomes are discussed, as well as potential contraindications to delayed cord clamping. Overall, delayed cord clamping offers potential benefits to the estimated 140 million neonates born globally every year, emphasizing the importance of this simple and no-cost strategy.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34856560     DOI: 10.1097/AOG.0000000000004625

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  In Reply.

Authors:  Ryan McAdams; Satyan Lakshminrusimha
Journal:  Obstet Gynecol       Date:  2022-04-01       Impact factor: 7.623

2.  Effects of spontaneous first breath on placental transfusion in term neonates born by cesarean section: A randomized controlled trial.

Authors:  Hasan Kilicdag; Deniz Parlakgumus; Suleyman Cansun Demir; Mehmet Satar
Journal:  Front Pediatr       Date:  2022-09-13       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.